| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |